1,25-Dihydroxyvitamin D3 Protects Against Macrophage-Induced Activation of NFκB and MAPK Signalling and Chemokine Release in Human Adipocytes

PLoS ONE - United States
doi 10.1371/journal.pone.0061707
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Points: 1,25 Dihydroxyvitamin D3 in Psoriasis

BMJ
1986English

Regulation of C/EBPβ Isoforms by MAPK Pathways in HL60 Cells Induced to Differentiate by 1,25-Dihydroxyvitamin D3

Experimental Cell Research
Cell Biology
2006English

Differential Catabolism of 22-Oxacalcitriol and 1,25-Dihydroxyvitamin D3 by Normal Human Peripheral Monocytes

Endocrinology
Endocrinology
1993English

1,25-Dihydroxyvitamin D3 Induces Collagen Binding to the Human Monocyte Line U937.

Journal of Clinical Investigation
Medicine
1987English

Induction of Monocytic Differentiation and Bone Resorption by 1,25-Dihydroxyvitamin D3.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1983English

Regulation of Lymphokine Production and Human T Lymphocyte Activation by 1,25-Dihydroxyvitamin D3. Specific Inhibition at the Level of Messenger RNA.

Journal of Clinical Investigation
Medicine
1987English

1,25-Dihydroxyvitamin D3 Inhibits the Differentiation and Migration of TH17 Cells to Protect Against Experimental Autoimmune Encephalomyelitis

PLoS ONE
Multidisciplinary
2010English

Analysis of 1,25-Dihydroxyvitamin D3 Receptors (VDR. In Basal Cell Carcinomas

American Journal of Pathology
Forensic MedicinePathology
1999English

Supplementation of N-Acetylcysteine Inhibits NFκB Activation and Protects Against Alloxan-Induced Diabetes in CD-1 Mice

FASEB Journal
BiochemistryBiotechnologyGeneticsMolecular BiologyMedicine
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy